Setmelanotide Injectable Solution 4 mg/mL Suppliers & Bulk Manufacturers

Available Forms: Injectable Solution

Available Strengths: 4 mg/mL

Reference Brands: Imcivree(Us & EU)

Category: Weight Loss drugs

Setmelanotide is a melanocortin-4 receptor agonist that regulates appetite and energy balance. It helps reduce hunger, support weight loss, and improve metabolic health in patients with rare genetic obesity syndromes. Benefits include appetite suppression, increased energy expenditure, and improved quality of life for affected individuals worldwide.

Product Description: Setmelanotide injectable solution, marketed as Imcivree, is approved in the US by the FDA and in the EU via EMA for treating obesity caused by rare genetic disorders such as POMC deficiency, PCSK1 deficiency, and Bardet-Biedl syndrome. Regulatory approval requires comprehensive dossiers including clinical efficacy, safety data, manufacturing standards, and pharmacovigilance plans. The FDA reviews detailed clinical trial and quality data for timely approval, while the EMA ensures regional safety and manufacturing compliance. For guidance on dossier preparation, regulatory pathways, and market access, visit PharmaTradz. Proper adherence supports swift approval, safe administration, and global availability to help patients worldwide manage rare genetic obesity effectively.